Shareholders' Equity (Details) - USD ($)			1 Months Ended	6 Months Ended
	Jul. 10, 2017	Jun. 06, 2017	Feb. 28, 2017	Jun. 30, 2017	Aug. 09, 2017	Apr. 06, 2017	Dec. 31, 2016	Mar. 31, 2016
Preferred Shares [Abstract]
Preferred shares, shares authorized (in shares)				2,000,000			2,000,000
Preferred shares, shares issued (in shares)				0			0
Preferred shares, shares outstanding (in shares)				0			0
Common Shares [Abstract]
Common stock, shares authorized (in shares)				150,000,000	150,000,000		150,000,000	125,000,000
Common stock, par value (in dollars per share)				$ 0			$ 0
Common stock, issued (in shares)				110,875,610			103,396,245
Common stock, outstanding (in shares)				110,875,610			102,776,539
Treasury stock (in shares)				0			619,706
Transfer of ownership at carrying value		$ 3,100,000
Subsequent Event [Member]
Common Shares [Abstract]
Common stock, shares authorized (in shares)					150,000,000
Common Stock [Member]
Common Shares [Abstract]
Number of shares sold (in shares)			7,453,704
Purchase price per share (in dollars per share)			$ 2.70
Proceeds from sale of stock			$ 18,500,000
Cell Cure Neurosciences, Ltd. [Member]
Common Shares [Abstract]
Ownership percentage				62.50%
Cell Cure Neurosciences, Ltd. [Member] | Subsequent Event [Member]
Common Shares [Abstract]
Ownership percentage	99.80%
Cell Cure Neurosciences, Ltd. [Member] | Common Stock [Member] | Subsequent Event [Member]
Common Shares [Abstract]
Number of shares sold (in shares)	4,924,542
Common shares issued value	$ 15,200,000
LifeMap Sciences, Inc. [Member]
Common Shares [Abstract]
Ownership percentage		82.00%					78.00%
LifeMap Solutions, Inc [Member]
Common Shares [Abstract]
Ownership percentage		100.00%
Cantor Fitzgerald & Co [Member]
Common Shares [Abstract]
Percentage of commission payable				3.00%
Cantor Fitzgerald & Co [Member] | Maximum [Member]
Common Shares [Abstract]
Aggregate offering price						$ 25,000,000